Evidence map›Paper›PMID 41606966›Full record

ArticleThe American journal of case reports2026

Postoperative Corneal Dellen Following PreserFlo MicroShunt: A Case Report.

Nawaf Zaid Almeshari, Norah Bin Dakhil, Konrad Schargel, Furat Alrajhi

Abstract readCase Reports
In one paragraph

Article in The American journal of case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nawaf Zaid AlmeshariDepartment of Glaucoma, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.
Norah Bin DakhilMedicine and Surgery College, King Saud University, Riyadh, Saudi Arabia.ORCID 0009-0005-3163-3163
Konrad SchargelDepartment of Glaucoma, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.ORCID 0000-0002-8550-0455
Furat AlrajhiDepartment of Glaucoma, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.ORCID 0000-0001-7591-8586

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND The PreserFlo MicroShunt is a subconjunctival drainage device increasingly used to manage open-angle glaucoma. While its safety profile is considered favorable compared with that of trabeculectomy, rare postoperative complications, including corneal surface pathology, can still be encountered. To our knowledge, corneal dellen has not been previously reported following PreserFlo implantation. CASE REPORT A 15-year-old boy with pathological myopia and Stickler syndrome underwent PreserFlo MicroShunt implantation for refractory secondary open-angle glaucoma. Two weeks postoperatively, he developed a temporal area of corneal stromal thinning consistent with dellen, located adjacent to an elevated bleb in the horizontal plane. Conservative therapy, including a switch from prednisolone acetate to loteprednol etabonate, intensive preservative-free lubrication, autologous serum drops, and bandage contact lens placement, was initiated. Full corneal re-epithelialization and recovery were achieved within 1 week, without compromising bleb function or intraocular pressure control. CONCLUSIONS Corneal dellen is a potential, although previously undocumented, complication of PreserFlo MicroShunt surgery, particularly when bleb elevation is prominent in areas not protected by the eyelid. Prompt recognition and targeted conservative therapy may allow for complete recovery while preserving device function and visual outcomes. Surgeons should monitor the ocular surface for this complication and adjust postoperative management accordingly.

Indexed as

Corneal DiseasesGlaucoma Drainage ImplantsGlaucoma, Open-AnglePostoperative ComplicationsAdolescentHumansMale

Identifiers

PMID41606966
PMCPMC12866257

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.